High-dose ifosfamide for soft tissue sarcomas: set the scene, or senescence?

Free article

Editorial

J Verweij. Ann Oncol. 1998 Aug.

Free article

. 1998 Aug;9(8):807-9.

doi: 10.1023/a:1008461922040.

No abstract available

Comment on

Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK).
Leyvraz S, Bacchi M, Cerny T, Lissoni A, Sessa C, Bressoud A, Hermann R. Leyvraz S, et al. Ann Oncol. 1998 Aug;9(8):877-84. doi: 10.1023/a:1008464504583. Ann Oncol. 1998. PMID: 9789611 Clinical Trial.
High-dose ifosfamide plus adriamycin in the treatment of adult advanced soft tissue sarcomas: is it feasible?
De Pas T, De Braud F, Orlando L, Nolè F, Munzone E, Zampino MG, Fazio N, Aapro MS, Goldhirsch A. De Pas T, et al. Ann Oncol. 1998 Aug;9(8):917-9. doi: 10.1023/a:1008311901856. Ann Oncol. 1998. PMID: 9789617 Clinical Trial.